ASCVD News

Latest Articles

• New Trial Shows Aggressive Cholesterol Targets Reduce Major Cardiovascular Events by One Third in High Risk Patients

  Published: Mar 30, 2026

  Section: Health

  The Ez-PAVE trial presented at ACC.26 confirms that lowering LDL cholesterol to a target of less than 55 mg/dL significantly improves outcomes for patients with atherosclerotic dis...

• Boston University Researchers Identify Modest Clinician Response to Elevated Lipoprotein(a) Levels in Primary Prevention Patients

  Published: Mar 16, 2026

  Section: Science & Tech

  A multicenter study presented at the American College of Cardiology reveals that nearly 80% of patients with high Lipoprotein(a) do not receive new preventive medications. While el...